Peptide record

TPDB45071

Antiviral standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45071
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 30-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
AIAEYAARIEALLRALQEQQEKNEAALREL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C148H248N44O48
DCGHMFPSTWV
A
3411.86
4.55
4
6
16
-2
2.19
-0.377
117.67
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
1490
0.44
5
Residue Composition
number
8
A
3
R
1
N
0
D
0
C
6
E
3
Q
0
G
0
H
2
I
5
L
1
K
0
M
0
F
0
P
0
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 8 R: 3 N: 1 D: 0 C: 0 E: 6 Q: 3 G: 0 H: 0 I: 2 L: 5 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
30 reviewed residue count
C148H248N44O48 sequence-only estimate (linear, free termini)
3411.86 sequence-only estimate (linear, free termini)
4.55 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
2.19 sequence-only estimate (linear, free termini)
-0.377 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA